Header Logo

A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis.

Sabet A. A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 May 02; 390(17):1632.

View in: PubMed